Newtown, Australia

Jane Hanrahan

This inventor holds 1 USPTO granted patent. Top assignees: Polychip Pharmaceuticals Pty Ltd., The University of Sydney. Active years: 2005.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jane Hanrahan: Innovator in Neurologically-Active Compounds

Introduction

Jane Hanrahan is a notable inventor based in Newtown, Australia. She has made significant contributions to the field of neuroscience through her innovative work on neurologically-active compounds. Her research focuses on enhancing cognitive activity and memory capacity in animals.

Latest Patents

Jane holds 1 patent for her invention related to neurologically-active compounds. The invention provides compounds of a specific formula, wherein R represents propyl, butyl, pentyl, neo-pentyl, or cyclohexyl, along with their salts. These compounds act as selective GABA receptor antagonists. Additionally, her invention outlines methods for enhancing cognitive activity and stimulating memory capacity in animals by administering effective amounts of these compounds.

Career Highlights

Throughout her career, Jane has worked with prominent organizations, including the University of Sydney Commercial Development & Industry Partnerships and Polychip Pharmaceuticals Pty Ltd. Her work in these institutions has allowed her to advance her research and contribute to the development of innovative solutions in the field of neuroscience.

Collaborations

Jane has collaborated with esteemed colleagues, including Mary Chebib and Graham A R Johnston. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Jane Hanrahan's contributions to the field of neurologically-active compounds highlight her innovative spirit and dedication to enhancing cognitive functions. Her work continues to inspire advancements in neuroscience and related fields.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…